Minvitro Embryo Transfer Catheters (ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C)

K253354 · Guangzhou Hehong Biotech Co., Ltd. · MQF · Feb 12, 2026 · Obstetrics/Gynecology

Device Facts

• Record ID: K253354
• Device Name: Minvitro Embryo Transfer Catheters (ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C)
• Applicant: Guangzhou Hehong Biotech Co., Ltd.
• Product Code: MQF · Obstetrics/Gynecology
• Decision Date: Feb 12, 2026
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 884.6110
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

Minvitro Embryo Transfer Catheters are used to place in vitro fertilized (IVF) embryos into the uterine cavity.

Device Story

Sterile, single-use embryo transfer catheters; used for IVF embryo placement into uterine cavity. System comprises transfer catheter, guide catheter, and optional stylet. Guide catheter inserted through cervix to facilitate transfer catheter placement; transfer catheter loaded with embryos and inserted through guide; embryos delivered via syringe (not provided) connected to hub. Features include echogenic tips/shafts for ultrasound visualization, depth marks, and pre-curved or straight guide configurations. Used in clinical settings by fertility specialists. Provides mechanical conduit for embryo delivery; echogenic features assist provider in accurate placement under ultrasound guidance. Benefits include standardized, controlled embryo transfer to the uterus.

Clinical Evidence

Bench testing only. Includes sterilization validation (ISO 11137), packaging integrity (ASTM F1886, F88, F1929), biocompatibility (ISO 10993-5, -10, -23), endotoxin testing (USP <85>), and Mouse Embryo Assay (MEA) showing ≥80% blastocyst development. Bench performance testing verified dimensions, tensile strength, bonding, ultrasound visibility, and flow rates before and after accelerated aging (ASTM F1980).

Technological Characteristics

Materials: PE, TPU, stainless steel, platinum-iridium, PEBAX, silicone, PU. Energy: None (mechanical). Dimensions: Transfer catheter OD 0.95mm, length 24.3cm; Guide catheter OD 2.30mm, length 17.5cm. Sterilization: Electron beam irradiation. Connectivity: None. Features: Echogenic tips/shafts, depth marks, luer hubs, optional stylet. Standards: ISO 11137, ISO 10993, ASTM D4169, ASTM F1886, ASTM F88, ASTM F1929, ASTM F1980, USP <85>.

Indications for Use

Indicated for the placement of in vitro fertilized (IVF) embryos into the uterine cavity.

Regulatory Classification

Identification

Assisted reproduction catheters are devices used in in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), or other assisted reproduction procedures to introduce or remove gametes, zygote(s), preembryo(s), and/or embryo(s) into or from the body. This generic type of device may include catheters, cannulae, introducers, dilators, sheaths, stylets, and component parts.

Special Controls

*Classification.* Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, biocompatibility testing, and clinical testing).

Predicate Devices

• Kitazato ET Catheters (K162878)

Submission Summary (Full Text)

{0}

FDA U.S. FOOD &amp; DRUG ADMINISTRATION

February 12, 2026

Guangzhou Hehong Biotech Co., Ltd.
Lena Liang
International Registration Specialist
A zone, 2/F, Building A, Huazi Industrial Park,
Shilou Town, Panyu District
Guangzhou, Guangdong 511447
CHINA

Re: K253354
Trade/Device Name: Minvitro Embryo Transfer Catheters (ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C)
Regulation Number: 21 CFR 884.6110
Regulation Name: Assisted Reproduction Catheters
Regulatory Class: II
Product Code: MQF
Dated: December 18, 2025
Received: December 18, 2025

Dear Lena Liang:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: The Center for Devices and Radiological Health (CDRH) does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register.

U.S. Food &amp; Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

{1}

K253354 - Lena Liang
Page 2

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13484 clause 8.3 (Nonconforming product), and ISO 13485 clause 8.5 (Corrective and preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the

{2}

K253354 - Lena Liang
Page 3

Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Monica D. Garcia -S

Monica D. Garcia, Ph.D.
Assistant Director
DHT3B: Division of Reproductive, Gynecology, and Urology Devices
OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

{3}

FORM FDA 3881 (8/23)
Page 1 of 1
PSC Publishing Services [phone]
EF

| DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use | Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below. |
| --- | --- |
| 510(k) Number (if known) K253354 | |
| Device Name Minvitro Embryo Transfer Catheters (ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C) | |
| Indications for Use (Describe) Minvitro Embryo Transfer Catheters are used to place in vitro fertilized (IVF) embryos into the uterine cavity. | |
| Type of Use (Select one or both, as applicable) ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | |
| CONTINUE ON A SEPARATE PAGE IF NEEDED. | |
| This section applies only to requirements of the Paperwork Reduction Act of 1995. *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* | |
| The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail] | |
| "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | |

{4}

K253354

Page 1 of 6

MINVTR 5 类拓

Embryo Transfer Catheter

# 510(k) Summary

# K253354

## Submitted by:

Submitter: Guangzhou Hehong Biotech Co., Ltd.
A zone, 2/F, Building A, Huazi Industrial Park,

Submitter Address: Shilou Town, Panyu District,
Guangzhou, 511447, China

Phone: [phone]

Fax: [phone]

Contact: Mr. Yu Feng, General Manager
([e-mail])
Lena Liang

Submission Correspondent: International Registration Specialist
Guangzhou Hehong Biotech Co., Ltd.
([e-mail])

Date prepared: February 11, 2026

## 1. Subject Device

| Trade Name: | Minvitro Embryo Transfer Catheters
(ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C) |
| --- | --- |
| Common Name: | Embryo Transfer Catheter |
| Regulation Name: | Assisted Reproduction Catheters |
| Regulation Number: | 21 CFR 884.6110 |
| Regulatory Class: | II |
| Product Code: | MQF (Catheter, Assisted Reproduction) |

## 2. Predicate Device

Kitazato ET Catheters (K162878) manufactured by Kitazato Corporation.

The predicate device has not been subject to a design-related recall.

## 3. Device Description

Minvitro Embryo Transfer Catheters are sterile single-use catheters used to place in vitro fertilized embryos into the uterine cavity. All the models of Minvitro Embryo Transfer Catheters have a transfer catheter and a guide catheter. A stylet is an optional accessory for specific models.

The guide catheter is delivered through the cervix first and is used to guide the insertion of the transfer catheter

{5}

Page 2 of 6
K253354
MINVTR 英拓
Embryo Transfer Catheter

holding the embryos into the uterine cavity. Two versions of guide catheters are provided:

- ETCA23175 series: Straight echogenic guide, with catheter shaft detectable under ultrasound to aid in catheter placement.
- ETCB20175 series: Pre-curved guide with a bulb tip and an adjustable positioner to facilitate proper positioning.

The transfer catheter is loaded with embryos and inserted into the guide catheter. Embryos are delivered into the uterine cavity by pressing a syringe (not provided with the catheters) connected to the transfer catheter's hub. The transfer catheter features a reinforced stainless steel support tube, with graduation marks printed on its proximal shaft. Variations with an additional echotip at the end of transfer catheter are offered for specific models (ETCB20175-ET and ETCB20175-ET-C) to assist visualization under ultrasound.

The stylet is an optional accessory for specific models. It is a malleable plastic-coated stainless steel core, which is used to provide additional rigidity and support during guide catheter insertion.

Device model specifications for the Minvitro Embryo Transfer Catheters are shown below.

| Model | Device component (features) | | |
| --- | --- | --- | --- |
| | Guide catheter | Transfer catheter | Stylet |
| ETCA23175 | OD 2.30 mm, Length 17.5 cm
Straight, echogenic | OD 0.95 mm,
Length 24.3 cm | N/A |
| ETCA23175-C | OD 2.30 mm, Length 17.5 cm
Straight, echogenic | OD 0.95 mm,
Length 24.3 cm | Length 20.3 cm |
| ETCB20175 | OD 2.30 mm, Length 17.5 cm Pre-curved, bulb tip & positioner | OD 0.95 mm,
Length 24.3 cm | N/A |
| ETCB20175-C | OD 2.30 mm, Length 17.5 cm Pre-curved, bulb tip & positioner | OD 0.95 mm,
Length 24.3 cm | Length 20.3 cm |
| ETCB20175-ET | OD 2.30 mm, Length 17.5 cm Pre-curved, bulb tip & positioner | OD 0.95 mm,
Length 24.3 cm,
With Echotip | N/A |
| ETCB20175-ET-C | OD 2.30 mm, Length 17.5 cm Pre-curved, bulb tip & positioner | OD 0.95 mm,
Length 24.3 cm,
With Echotip | Length 20.3 cm |

## 4. Indications for Use Statement

Minvitro Embryo Transfer Catheters are used to place in vitro fertilized (IVF) embryos into the uterine cavity.

{6}

Page 3 of 6
K253354
MINVTR 英拓
Embryo Transfer Catheter

5. Comparison of Intended Use and Technological Characteristics of the Subject Device and Predicate Device

| Parameter | Subject Device
K253354 | Predicate Device
K162878 | Equivalence |
| --- | --- | --- | --- |
| Manufacturer | Guangzhou Hehong Biotech Co., Ltd | Kitazato Corporation | N/A |
| Device Name | Minvitro Embryo Transfer Catheters | Kitazato ET Catheters | N/A |
| Model | ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C | Type 2 EC-PRO Supported [Version 2 and 8], Type 4 EC-PRO Master Supported [Version 2 and 8], Type 5 Stylet Cannula [Version 2] | N/A |
| Product Code | MQF | MQF | Same |
| Regulation | 884.6110 | 884.6110 | Same |
| Indication for Use | Minvitro Embryo Transfer Cathers are used to place in vitro fertilized (IVF) embryos into the uterine cavity. | The Kitazato ET Catheters are intended for ultrasound guided introduction of embryos into the uterine cavity following in vitro fertilization.

Kitazato ET Catheters are provided in various configurations (Type 1 through Type 5), which consist of the following components:
• Transfer Catheter, for delivery of embryos into the uterine cavity;
• Guide Catheter, to guide the insertion of the Transfer Catheter and reinforce it during use;
• Trial Catheter, used to confirm the curvature of the cervix and if the cervix is passable;
• Stylet Sheath, used to increase the strength of the Guide Catheter during insertion. | Different. |

{7}

Page 4 of 6
K253354
MINVTR 美拓
Embryo Transfer Catheter

| Parameter | Subject Device
K253354 | Predicate Device
K162878 | Equivalence |
| --- | --- | --- | --- |
| Design features | Transfer catheter:
• Open-end shaft with depth marks and protective sleeve
• Luer connector
• Outer supporting tube (stiffener)
• With or without echogenic band on the tip (Echotip)

Guide catheter:
• Echogenic straight shaft with depth marks (ETCA23175 series)
• Pre-curved shaft with depth marks, a positioner and bulb-tip design (ETCB20175 series)
• Handle | Transfer catheter:
• Open-end shaft with depth marks and protective sleeve
• Luer connector
• Outer stiffener
• Echo line

Guide catheter:
• Straight or curved shaft with depth marks
• Handle/connector

Trial: Same as corresponding size transfer catheter, but with closed end. | Different. |
| Inclusion of a stylet | Yes
(ETCA23175-C, ETCB20175-C, ETCB20175-ET-C) | Yes (Type 5) | Same |
| Dimension | Transfer catheter:
Length 24.3 cm
OD 0.95 mm (2.85 Fr)

Guide catheter:
Length 17.5 cm
OD 2.30 mm (6.9 Fr) | Catheter length: 18 and 23 cm
Catheter outer diameter: 1.55 mm / 4.7 Fr

Guide length: 14 and 19 cm | Different. |
| Material | Transfer catheter: Polyethylene (PE), thermoplastic polyurethane (TPU), stainless steel, platinum-iridium alloy, printing ink

Pre-curved guide: PEBAX, silicone, PE, printing ink

Straight guide: Polyurethane (PU), PE, printing ink | Catheter shaft: Polyurethane
Guide: Fluoric resin
Luer connector: ABS
Outer stiffener: Stainless steel | Different. |
| Sterilization method | Electron beam irradiation | Ethylene oxide (ETO) | Different. |
| Single Use | Yes | Yes | Same |

{8}

Page 5 of 6
K253354
MINVTR 美拓
Embryo Transfer Catheter

| Parameter | Subject Device
K253354 | Predicate Device
K162878 | Equivalence |
| --- | --- | --- | --- |
| Shelf-life | 2 years | 3 years | Different. |
| Mouse Embryo Assay | One-cell system ≥80% embryos developed to blastocyst in 96 hours | 1-cell, ≥80% expanded blastocysts at 96 hours | Same. |
| Endotoxin | < 20 EU/device | < 20 EU/device | Same. |

Despite differences in their indication for use statements, the subject device and the predicate device have the same intended use (i.e., transfer of embryos into the uterine cavity). As shown above, the subject device and predicate device have different technological characteristics, including differences in design features, materials, dimension, sterilization method and shelf life; however, the differences noted do not raise different questions of safety and effectiveness.

# 6. Summary of Non-Clinical Performance Data

The following studies have been performed to support of the substantial equivalence to the predicate device:

- Sterilization validation testing per ISO 11137-1:2006 and ISO 11137-2:2013
- Transportation Simulation testing per ASTM D4169-22
- Packaging integrity testing:
- Visual inspection per ASTM F1886/F1886M-16
- Seal Strength testing per ASTM F88/ F88M-23
- Dye Penetration test per ASTM F1929-23
- Biocompatibility evaluation conducted in accordance with the 2023 FDA guidance, Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices — Part 1: Evaluation and testing within a risk management process." Testing included the following assessments:
- Cytotoxicity per ISO 10993-5: 2009
- Sensitization ISO 10993-10: 2021
- Irritation per ISO 10993-23: 2021

Testing showed the device material to be non-cytotoxic, non-sensitizing, and non-irritating.

- Endotoxin testing conducted before and after aging per USP &lt;85&gt; with acceptance criteria: &lt;20 EU/device.
- Mouse embryo assay (MEA) conducted before and after aging per the 2021 FDA guidance, Mouse Embryo Assay for Assisted Reproduction Technology Devices with specification: One-cell System ≥80% embryos developed to blastocyst in 96 hours.
- Bench performance conducted before and after accelerated aging to the equivalent of two (2) years of real-time aging in accordance with ASTM F1980-21 demonstrated that all predetermined acceptance

{9}

Page 6 of 6
K253354
MINVTR 英拓
Embryo Transfer Catheter

criteria were met in the following tests:

- Appearance
- Dimension verification
- Transfer catheter and stylet compatibility with guide catheter
- Depth mark location and color-fastness
- Tensile strength of catheter shaft
- Bonding strength of device connections
- Dislodgement of positioner
- Tip drop when held horizontally
- Removal force of Echotip
- Ultrasound visibility
- Verification of luer hub
- Aspiration, leakage, and flow rate of transfer catheter
- Corrosion resistance, toughness and stiffness of stainless steel support tube

## 7. Conclusion

The results of the testing described above demonstrate that Minvitro Embryo Transfer Catheters are as safe and effective as the predicate device and supports a determination of substantial equivalence.